SUBSCRIBE
SUBSCRIBE
News   Business

Valeant Pharmaceuticals International Reports 2006 Second Quarter Results; Product Sales Increase 15 Percent; Restructuring Initiative Taking Hold

August 3, 2006 | 
1 min read
COSTA MESA, Calif.--(BUSINESS WIRE)--Aug. 3, 2006--Valeant Pharmaceuticals International (NYSE:VRX) today announced results for the 2006 second quarter.
Earnings
Valeant Pharmaceuticals International
MORE ON THIS TOPIC
Boxes and prohibition symbol NO. Trade wars. A ban on the import of goods. Impossibility of transportation, oversupply. Shortage of goods. Sanctions and embargoes. Confiscation of contraband.
Duchenne muscular dystrophy
Following Sarepta’s Lead, Roche Suspends Elevidys Shipments to Some Ex-US Countries
July 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Sarepta’s Wild Week, CDER’s New Leader, FDA Rejections, Manufacturing Billions
July 23, 2025
 · 
1 min read
 · 
Jef Akst
Close-Up Of Syringe With Bottles Against Blue Background
Mergers & acquisitions
Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition
July 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: AstraZeneca's manufacturing facility in Sweden
Manufacturing
With Potential Tariffs Weeks Away, AstraZeneca Makes $50B U.S. Manufacturing Push
July 22, 2025
 · 
2 min read
 · 
Tristan Manalac